Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.
Cabral-Marques O, Halpert G, Schimke LF, Ostrinski Y, Vojdani A, Baiocchi GC, Freire PP, Filgueiras IS, Zyskind I, Lattin MT, Tran F, Schreiber S, Marques AHC, Plaça DR, Fonseca DLM, Humrich JY, Müller A, Giil LM, Graßhoff H, Schumann A, Hackel A, Junker J, Meyer C, Ochs HD, Lavi YB, Scheibenbogen C, Dechend R, Jurisica I, Schulze-Forster K, Silverberg JI, Amital H, Zimmerman J, Heidecke H, Rosenberg AZ, Riemekasten G, Shoenfeld Y. Cabral-Marques O, et al. Among authors: heidecke h. Nat Commun. 2022 Mar 9;13(1):1220. doi: 10.1038/s41467-022-28905-5. Nat Commun. 2022. PMID: 35264564 Free PMC article.
Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms.
Fonseca DLM, Jäpel M, Gyamfi MA, Filgueiras IS, Baiochi GC, Ostrinski Y, Halpert G, Lavi YB, Vojdani E, Silva-Sousa T, Usuda JN, E Silva JCS, Freire PP, Nóbile AL, Adri AS, Barcelos PM, Corrêa YLG, do Vale FYN, Lopes LO, Schmidt SL, Wang X, Vahldieck C, Fels B, Schimke LF, Cabral-Miranda G, Hirata MH, AKhan TA, Yu YA, Dalmolin RJ, Amital H, Vojdani A, Dias HD, Nakaya H, Ochs HD, Silverberg JI, Zimmerman J, Zyskind I, Rosenberg AZ, Schulze-Forster K, Heidecke H, Catar R, Moll G, Hackel A, Kusche-Vihrog K, Shoenfeld Y, Riemekasten G, Akbarzadeh R, Marques AHC, Cabral-Marques O. Fonseca DLM, et al. Among authors: heidecke h. NPJ Syst Biol Appl. 2025 Jan 13;11(1):7. doi: 10.1038/s41540-025-00488-z. NPJ Syst Biol Appl. 2025. PMID: 39805853 Free PMC article.
Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN).
Goutaudier V, Danger R, Catar RA, Racapé M, Philippe A, Elias M, Raynaud M, Aubert O, Bouton D, Girardin F, Vicaut É, Yaiche S, Demotes J, Heidecke H, Taupin JL, Randoux-Lebrun C, Zaidan M, Papuchon E, Le Mai H, Nguyen TV, Moreso F, Berney T, Villard J, Legendre C, Dragun D, Papalois V, Potena L, Giral M, Gourraud PA, Brouard S, Crespo E, Halleck F, Budde K, Bestard O, Loupy A, Lefaucheur C; EU-TRAIN Consortium. Goutaudier V, et al. Among authors: heidecke h. Kidney Int. 2024 Nov;106(5):943-960. doi: 10.1016/j.kint.2024.07.027. Epub 2024 Aug 27. Kidney Int. 2024. PMID: 39197587 Free article.
Angiotensin II Type 2 Receptor Antibodies in Glomerular Diseases.
Szymczak M, Heidecke H, Żabińska M, Rukasz D, Wiśnicki K, Kujawa K, Kościelska-Kasprzak K, Krajewska M, Banasik M. Szymczak M, et al. Among authors: heidecke h. Arch Immunol Ther Exp (Warsz). 2024 Aug 19;72(1). doi: 10.2478/aite-2024-0017. eCollection 2024 Jan 1. Arch Immunol Ther Exp (Warsz). 2024. PMID: 39166802 Free article.
Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS).
Mundorf AK, Semmler A, Heidecke H, Schott M, Steffen F, Bittner S, Lackner KJ, Schulze-Bosse K, Pawlitzki M, Meuth SG, Klawonn F, Ruhrländer J, Boege F. Mundorf AK, et al. Among authors: heidecke h. Vaccines (Basel). 2024 Jul 18;12(7):790. doi: 10.3390/vaccines12070790. Vaccines (Basel). 2024. PMID: 39066428 Free PMC article.
Intensive receptor blockade and plasma exchange to treat refractory scleroderma renal crisis in patients with agonistic autoantibodies targeting the angiotensin II type 1 and endothelin-1 type A receptors.
Hegner B, Callaghan J, Schindler R, Heidecke H, Riemekasten G, Philippe A, Catar R. Hegner B, et al. Among authors: heidecke h. J Scleroderma Relat Disord. 2024 Feb;9(1):NP1-NP6. doi: 10.1177/23971983231168193. Epub 2023 Apr 30. J Scleroderma Relat Disord. 2024. PMID: 38333524
Allergic manifestations in women with silicone breast implants.
Tanay G, Halpert G, Dotan A, Sharif K, Tsur AM, Shefler I, Heidecke H, Amital H, Tanay A, Mekori YA, Shoenfeld Y. Tanay G, et al. Among authors: heidecke h. Hum Immunol. 2024 Jan;85(1):110747. doi: 10.1016/j.humimm.2023.110747. Epub 2023 Dec 27. Hum Immunol. 2024. PMID: 38155072
99 results